Skip to content

Clinical trials

Phase 2/3 Lymphoma, Large B-Cell, Diffuse trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 2/3 Country / region: Poland Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20162
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting1
Completed1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation1
Karyopharm Therapeutics Inc1
Merck Sharp & Dohme LLC1
TG Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse4
Leukemia, Lymphocytic, Chronic, B-Cell1
Lymphoma, B-Cell, Marginal Zone1
Lymphoma, Follicular1
Lymphoma, Mantle-Cell1
Lymphoma, Non-Hodgkin1
Recurrence1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.